Search Results - "Mitterbauer, Christa"

Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation by Koppelstaetter, Christian, Schratzberger, Gabriele, Perco, Paul, Hofer, Johannes, Mark, Walter, Öllinger, Robert, Oberbauer, Rainer, Schwarz, Christoph, Mitterbauer, Christa, Kainz, Alexander, Karkoszka, Henryk, Wiecek, Andrzej, Mayer, Bernd, Mayer, Gert

“…Summary Although chronological donor age is the most potent predictor of long‐term outcome after renal transplantation, it does not incorporate individual…”
Get full text

Health-related quality of life outcomes after kidney transplantation by Fiebiger, Wolfgang, Mitterbauer, Christa, Oberbauer, Rainer

“…With the improvements in short and long term graft and patient survival after renal transplantation over the last two decades Health-Related Quality of Life…”
Get full text

Effects of bisphosphonates on bone loss in the first year after renal transplantation—a meta-analysis of randomized controlled trials by Mitterbauer, Christa, Schwarz, Christoph, Haas, Martin, Oberbauer, Rainer

“…Background. Bone loss remains a serious problem after kidney transplantation and is most pronounced during the first months after engraftment. Bisphosphonates…”
Get full text

Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation by HEINZE, Georg, MITTERBAUER, Christa, REGELE, Heinz, KRAMAR, Reinhard, WINKELMAYER, Wolfgang C, CURHAN, Gary C, OBERBAUER, Rainer

“…Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II type 1 receptor blockers (ARB) reduce cardiovascular death in the general population, but…”
Get full text

Bone disease after kidney transplantation by Mitterbauer, Christa, Oberbauer, Rainer

“…Post-transplant renal osteopathy (ROP) remains a serious problem, which contributes to substantial long-term morbidity of the graft recipients. Bone loss is…”
Get more information

Steroid Pretreatment of Organ Donors to Prevent Postischemic Renal Allograft Failure: A Randomized, Controlled Trial by KAINZ, Alexander, WILFLINGSEDER, Julia, MITTERBAUER, Christa, HALLER, Maria, BURGHUBER, Christopher, PERCO, Paul, LANGER, Robert M, HEINZE, Georg, OBERBAUER, Rainer

“…Posttransplantation acute renal failure (ARF) occurs in roughly 25% of recipients of organs from deceased donors. Inflammation in the donor organ is associated…”
Get full text

Statin Use Is Associated with Prolonged Survival of Renal Transplant Recipients by WIESBAUER, Franz, HEINZE, Georg, MITTERBAUER, Christa, HARNONCOURT, Franz, HÖRL, Walter H, OBERBAUER, Rainer

“…The efficacy of statins for the prevention of cardiovascular events is well established in the general population but remains unknown in renal transplant…”
Get full text

Age and sex are sufficient for predicting fractures occurring within 1 year of hemodialysis treatment by Mitterbauer, Christa, Kramar, Reinhard, Oberbauer, Rainer

“…Abstract Background The incidence of fractures averages 20 per 1000 hemodialysis patient years at risk. This study sought to design and evaluate the utility of…”
Get full text

Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation by Haas, Martin, Leko-Mohr, Zdenka, Roschger, Paul, Kletzmayr, Josef, Schwarz, Christoph, Mitterbauer, Christa, Steininger, Rudolf, Grampp, Stefan, Klaushofer, Klaus, Delling, Günter, Oberbauer, Rainer

“…Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation. Bisphosphonates can prevent bone mineral density loss after renal…”
Get full text

Flow monitoring: performance characteristics of ultrasound dilution versus color Doppler ultrasound compared with fistulography by Schwarz, Christoph, Mitterbauer, Christa, Boczula, Maryla, Maca, Thomas, Funovics, Martin, Heinze, Georg, Lorenz, Matthias, Kovarik, Josef, Oberbauer, Rainer

“…Background: Measurement of access blood flow is the preferred noninvasive screening test for hemodialysis arteriovenous (AV) fistula stenosis. However,…”
Get full text

Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function by KAINZ, Alexander, PERCO, Paul, MAYER, Bernd, SOLEIMAN, Afschin, STEININGER, Rudolf, MAYER, Gert, MITTERBAUER, Christa, SCHWARZ, Christoph, MEYER, Timothy W, OBERBAUER, Rainer

“…Donor factors such as age profoundly influence long-term graft function after cadaveric renal transplantation, but the molecular signature of these aspects in…”
Get full text

Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function by Hauser, Peter, Schwarz, Christoph, Mitterbauer, Christa, Regele, Heinz M, Mühlbacher, Ferdinand, Mayer, Gert, Perco, Paul, Mayer, Bernd, Meyer, Timothy W, Oberbauer, Rainer

“…Roughly 25% of cadaveric, but rarely living donor renal transplant recipients, develop postischemic acute renal failure, which is a main risk factor for…”
Get full text

Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation by Schwarz, Christoph, Mitterbauer, Christa, Heinze, Georg, Woloszczuk, Wolfgang, Haas, Martin, Oberbauer, Rainer

“…Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation. We recently showed that two doses of 4mg of…”
Get full text

Calcineurin Inhibitor-Based Immunosuppressive Therapy, Donor Age, and Long-Term Outcome After Kidney Transplantation by HEINZE, Georg, OBERBAUER, Rainer, KAINZ, Alexander, MITTERBAUER, Cllrista, KOPPELSTAETTER, Christian, HÖRL, Walter H, MAYER, Gert

“…It is unclear whether the choice of maintenance immunosuppression modulates the negative effect of advanced donor age on outcome after renal transplantation…”
Get full text

ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations by Mitterbauer, Christa, Heinze, Georg, Kainz, Alexander, Kramar, Reinhard, Hörl, Walter H., Oberbauer, Rainer

“…Background. Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II type 1 receptor blockers (ARB) are frequently prescribed to renal transplant…”
Get full text

Alterations in Gene Expression in Cadaveric vs. Live Donor Kidneys Suggest Impaired Tubular Counterbalance of Oxidative Stress at Implantation by Kainz, Alexander, Mitterbauer, Christa, Hauser, Peter, Schwarz, Christoph, Regele, Heinz M., Berlakovich, Gabriela, Mayer, Gert, Perco, Paul, Mayer, Bernd, Meyer, Timothy W., Oberbauer, Rainer

“…Recipients of live donor transplant kidneys (LIV) exhibit a significantly longer allograft half‐life compared with cadaveric donor organs (CADs). The reasons…”
Get full text

Transcriptional response in the unaffected kidney after contralateral hydronephrosis or nephrectomy by Hauser, Peter, Kainz, Alexander, Perco, Paul, Bergmeister, Helga, Mitterbauer, Christa, Schwarz, Christoph, Regele, Heinz M., Mayer, Bernd, Meyer, Timothy W., Oberbauer, Rainer

“…Transcriptional response in the unaffected kidney after contralateral hydronephrosis or nephrectomy. Unilateral loss of kidney function is followed by…”
Get full text

Impaired tubulointerstitial expression of endothelin-1 and nitric oxide isoforms in donor kidney biopsies with postischemic acute renal failure by Mitterbauer, Christa, Schwarz, Christoph, Hauser, Peter, Steininger, Rudolf, Regele, Heinz M, Rosenkranz, Alexander, Oberbauer, Rainer

“…About 30% of cadaveric renal allografts, but almost never living-donor kidneys, develop postischemic acute renal-transplant failure (ARF). We therefore…”
Get full text

Rational decision making in the treatment of renal artery stenosis by Mitterbauer, Christa, Oberbauer, Rainer

Get more information